A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results

29 August 2025 (07:00 - 18:00)

Organised by:

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

8 More presentations in this session

Presentation thumbnail

Discussant - Pharmacotherapy

Presentation thumbnail

SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

Doctor K. Dimitriadis (Athens, GR)

Presentation thumbnail

Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction

Doctor P. Sun (Tianjin, CN)

Presentation thumbnail

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

Doctor M. Galli (Rome, IT)

Presentation thumbnail

Comparative effectiveness of GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis with intervention ranking

Doctor M. Rahman (Flushing, US)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Congress Presentation

Novel inhalation approaches for targeted treatment in heart failure

Congress Session

Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources